Qube Research & Technologies (QRT)
ANAB icon

Qube Research & Technologies (QRT)’s AnaptysBio ANAB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Sell
228,777
-25,959
-10% -$1.57M 0.01% 1041
2026
Q1 		$14.1M Buy
254,736
+145,771
+134% +$7.84M 0.02% 1073
2025
Q4 		$5.28M Buy
+108,965
New +$4.25M 0.01% 1739
2025
Q1 		– Sell
-125,070
Closed -$1.66M – 3468
2024
Q4 		$1.66M Buy
125,070
+72,042
+136% +$1.75M ﹤0.01% 1959
2024
Q3 		$1.78M Buy
+53,028
New +$1.81M ﹤0.01% 1803
2024
Q2 		– Sell
-28,542
Closed -$643K – 3764
2024
Q1 		$643K Buy
28,542
+25,903
+982% +$613K ﹤0.01% 2398
2023
Q4 		$56.5K Sell
2,639
-10,826
-80% -$187K ﹤0.01% 3278
2023
Q3 		$242K Sell
13,465
-69
-0.5% -$1.32K ﹤0.01% 2330
2023
Q2 		$275K Buy
+13,534
New +$274K ﹤0.01% 1681

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ANAB Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its AnaptysBio (ANAB) stake by 10% in Q2 2026, selling an estimated $1.57M and leaving 228,777 shares worth $15.4M. The position accounts for 0.01% of the portfolio, ranked #1041.

Qube Research & Technologies (QRT) first reported a position in ANAB in Q2 2023 and has held it in 9 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Qube Research & Technologies (QRT) held 228,777 shares of AnaptysBio worth $15.4M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 25,959 AnaptysBio shares in Q2 2026, an estimated $1.57M.
  • AnaptysBio made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1041 holding.
  • Qube Research & Technologies (QRT) first reported a position in AnaptysBio in Q2 2023 and has held it in 9 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.